Cerus reported $-11126000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Atrion ATRI:US 9.48M 317K
Cerulean Pharma CERU:US $ -12668940 3.51M
Cerus CERS:US $ -11126000 3.28M
Cytori Therapeutics CYTX:US $ -3499000 924K
GRIFOLS GRF:SM € 250.6M 37.64M
Haemonetics HAE:US $ 24.51M 23.12M
Meridian Bioscience VIVO:US $ 8.49M 7.19M
Neogen NEOG:US $ 21.74M 1.49M
Nuvasive NUVA:US $ -6.63M 17.38M
Orasure Technologies OSUR:US $ -13.01M 14.81M
Quidel QDEL:US $ 281.84M 258.54M
Rockwell Medical RMTI:US $ -6.97M 0.85M
Sientra SIEN:US -11694000 2.54M
Staar Surgical STAA:US $ 7.84M 2.81M
Terumo 4543:JP Y 29624M 6609M